GENERATION OF HER-2 NEU-SPECIFIC CYTOTOXIC NEUTROPHILS IN-VIVO - EFFICIENT ARMING OF NEUTROPHILS BY COMBINED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND FC-GAMMA RECEPTOR-I BISPECIFIC ANTIBODIES/
Iafm. Heijnen et al., GENERATION OF HER-2 NEU-SPECIFIC CYTOTOXIC NEUTROPHILS IN-VIVO - EFFICIENT ARMING OF NEUTROPHILS BY COMBINED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND FC-GAMMA RECEPTOR-I BISPECIFIC ANTIBODIES/, The Journal of immunology, 159(11), 1997, pp. 5629-5639
Abs are able to induce inflammatory antitumor responses by recruiting
IgG Fc receptor (Fc gamma R)-bearing cytotoxic effector cells. We rece
ntly described the capacity of the high affinity Fc gamma RI (CD64) to
trigger cytotoxic activity of neutrophils (PMN) during granulocyte CS
F (G-CSF) treatment, To take advantage of Fc gamma RI as a cytotoxic t
rigger molecule on PMN, two Ab constructs were prepared, We show that
a chimeric human IgG1 Ab (Ch520C9) and an anti-Fc gamma RI bispecific
Ab (BsAb; 22x520C9), both directed to the proto-oncogene product HER-2
/neu, interact with Fc gamma RI. In addition, both Ab constructs media
te enhanced lysis of HER-2/neu-expressing tumor cells by G-CSF-primed
PMN. However, engagement of Fc gamma RI by Ch520C9 was inhibited by hu
man serum IgG, thereby abrogating the enhanced Ch520C9-mediated cytoto
xicity, BsAb 22x520C9, which binds Fc gamma RI outside the ligand bind
ing domain, effectively recruits the cytotoxic potential of Fc gamma R
I on G-CSF-primed PMN regardless of the presence of human serum. These
results indicate that under physiologic conditions, serum IgG impairs
activation of Fc gamma RI-mediated cytotoxicity by conventional antit
umor Abs, The IgG blockade can be circumvented with anti-Fc gamma RI B
sAbs, Using human Fc gamma RI transgenic mice we demonstrate that BsAb
22x520C9 is able to engage Fc gamma RI in vivo. BsAb 22x520C9 injecte
d i.v. was readily detected on circulating PMN of G-CSF-treated transg
enic animals, In addition, we showed that PMN remain ''armed'' with Bs
Ab 22x520C9 during migration to inflammatory sites, and that after iso
lation such PMN specifically lyse HER-2/neu-expressing tumor cells, Th
ese results point to the possibility of targeting anti-Fc gamma RI BsA
bs to G-CSF-primed PMN in vivo, endowing them with specific anti-tumor
activity.